论文部分内容阅读
目的:探讨妇科千金片联合阿莫西林克拉维酸钾片治疗慢性盆腔炎的临床疗效及安全性。方法:选择我院收治的慢性盆腔炎患者60例,将其随机分为观察组对照组,每组30例,对照组给予阿莫西林克拉维酸钾片,观察组在对照组基础上加用妇科千金片,两组均连续治疗2周,比较两组临床疗效、各症状评分、盆腔炎性包块改善情况以及不良反应。结果:观察组治疗总有效率为93.33%,对照组治疗总有效率为73.33%,两组比较,差异具统计学意义(P<0.05);治疗后,两组患者各临床症状评分均较治疗前显著改善(P<0.05),且观察组改善情况显著优于对照组(P<0.05);治疗后,两组患者盆腔炎性包块显著较治疗前缩小(P<0.05),且观察组治疗后包括显著小于对照组(P<0.05);治疗期间,观察组不良反应发生率6.67%、对照组3.33%,两组比较差异不存在统计学意义(P<0.05)。结论:妇科千金片联合阿莫西了拉维酸钾片治疗慢性盆腔炎其疗效确切,能够显著改善患者临床症状,并有效缩小盆腔炎性包块,治疗安全可靠,值得临床推广运用。
Objective: To investigate the clinical efficacy and safety of gynecological Qianjin tablets combined with amoxicillin and potassium clavulanate in the treatment of chronic pelvic inflammatory disease. Methods: Sixty patients with chronic pelvic inflammatory disease admitted to our hospital were randomly divided into observation group and control group, with 30 cases in each group. The control group was given amoxicillin and potassium clavulanate tablets. The observation group was added on the basis of the control group Gynecology daughter gold tablets, two groups were treated for 2 weeks, the clinical efficacy of the two groups were compared, the symptom score, pelvic inflammatory mass improvement and adverse reactions. Results: The total effective rate of the observation group was 93.33%, the total effective rate of the control group was 73.33%, the difference was statistically significant (P <0.05); after treatment, the scores of clinical symptoms in both groups were significantly higher than those in the treatment group (P <0.05), and the improvement in the observation group was significantly better than that in the control group (P <0.05). After treatment, the pelvic inflammatory mass in both groups was significantly reduced (P <0.05), and the observation group The incidence of adverse reactions was 6.67% in the observation group and 3.33% in the control group during the treatment. There was no significant difference between the two groups (P <0.05). Conclusion: The combination of gynecology Qianjin tablets and amoxicillin potassium tablets for the treatment of chronic pelvic inflammatory disease its exact effect, can significantly improve the clinical symptoms and reduce the pelvic inflammatory mass, the treatment of safe and reliable, worthy of clinical promotion and use.